Cross‐Sectional Serological Profile Anti‐AChR by ELISA of a Brazilian Cohort of Patients With Suspected Myasthenia Gravis
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/3869273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 17.11.2026. Verfasst von Lucas Grobério Moulim de Moraes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences and Behavioral Sciences, Neurology Division, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão …. Hauptthemen laut MEDLINE: Myasthenia Gravis, Receptors, Cholinergic, Autoantibodies. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Apoio ao Ensino, Pesquisa e Assistência (FAEPA).
Abstract (Originalsprache)
Background
Myasthenia gravis (MG) is most commonly mediated by antibodies against the acetylcholine receptor (AChR). Although radioimmunoprecipitation assay (RIPA) is the reference standard, enzyme‐linked immunosorbent assay (ELISA) is widely used in routine practice, particularly in low‐ and middle‐income settings, despite moderate sensitivity.
Methods
We retrospectively reviewed patients investigated for suspected myasthenic syndromes who underwent anti‐AChR IgG testing by ELISA between 2017 and 2025 at a tertiary MG center in Brazil. Demographic, clinical, electrophysiological, and serological data were analyzed. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis and multivariable logistic regression. Associations between antibody status and titers with MG phenotype, MGFA class, and MG‐ADL scores were evaluated.
Results
Among 321 individuals, 212 (66.0%) were diagnosed with MG. Anti‐AChR positivity was strongly associated with MG ( p < 0.001), with observed sensitivity of 64.9% and specificity of 98.2%. Overall discriminative performance was high (area under the curve [AUC] 0.844). Antibody titers were significantly higher in MG versus non‐MG patients ( p < 0.001) and in generalized versus ocular MG. Seropositivity was more frequent in very late‐onset (LO) MG ( p = 0.001). Ocular and bulbar presentations and non‐Caucasian ethnicity were independently associated with MG; repetitive nerve stimulation positivity showed the strongest association, although this is partly attributable to its inclusion in the diagnostic definition. Antibody positivity correlated with greater disease severity (MGFA ≥ IIb and higher MG‐ADL scores), although correlations between titers and severity were modest. Immunotherapy was not associated with reduced seropositivity.
Conclusions
Anti‐AChR ELISA showed excellent specificity and good diagnostic discrimination, with moderate sensitivity in this real‐world cohort. Because ELISA‐negative samples were not retested by RIPA or cell‐based assays (CBAs), this sensitivity should not be extrapolated to anti‐AChR antibody testing overall.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences and Behavioral Sciences, Neurology Division, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão Preto, São Paulo, Brazil, usp.br.
- Laboratory of Applied and Experimental Neurology (LNAE), University of São Paulo (FMRP-USP), Ribeirão Preto, São Paulo, Brazil, usp.br.
ORCID-Profile: Lucas Grobério Moulim de Moraes, Manoella Guerra de Albuquerque Bueno, Amanda Vitoria Freire de Oliveira, Giuliana França Teixeira Mandia Grossi, Milena Bongiorno Levignali, Carolina Lavigne Moreira, André Cleriston José Dos Santos, Rodrigo Siqueira Soares Frezatti, Claudia Ferreira da Rosa Sobreira, Wilson Marques Junior, Pedro José Tomaselli
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Apoio ao Ensino, Pesquisa e Assistência (FAEPA)
Zitieren
APA
de Moraes, L. G. M., de Albuquerque Bueno, M. G., de Oliveira, A. V. F., Grossi, G. F. T. M., Levignali, M. B., Moreira, C. L., Dos Santos, A. C. J., Frezatti, R. S. S., da Rosa Sobreira, C. F., Junior, W. M., & Tomaselli, P. J. (2026). Cross‐Sectional Serological Profile Anti‐AChR by ELISA of a Brazilian Cohort of Patients With Suspected Myasthenia Gravis. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/3869273
Vancouver
de Moraes LGM, de Albuquerque Bueno MG, de Oliveira AVF, Grossi GFTM, Levignali MB, Moreira CL, et al. Cross‐Sectional Serological Profile Anti‐AChR by ELISA of a Brazilian Cohort of Patients With Suspected Myasthenia Gravis. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/3869273
BibTeX
@article{deMoraes2026,
author = {de Moraes, Lucas Grobério Moulim and de Albuquerque Bueno, Manoella Guerra and de Oliveira, Amanda Vitoria Freire and Grossi, Giuliana França Teixeira Mandia and Levignali, Milena Bongiorno and Moreira, Carolina Lavigne and Dos Santos, André Cleriston José and Frezatti, Rodrigo Siqueira Soares and da Rosa Sobreira, Claudia Ferreira and Junior, Wilson Marques and Tomaselli, Pedro José},
title = {Cross‐Sectional Serological Profile Anti‐AChR by ELISA of a Brazilian Cohort of Patients With Suspected Myasthenia Gravis},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/3869273}
}
EUVIMED